Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H17NO |
| Molecular Weight | 179.2588 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
InChI
InChIKey=FMCGSUUBYTWNDP-ONGXEEELSA-N
InChI=1S/C11H17NO/c1-9(12(2)3)11(13)10-7-5-4-6-8-10/h4-9,11,13H,1-3H3/t9-,11-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/8951157
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8951157
L-methylephedrine is an isomer of DL form, which possesses beta 1-adrenoceptor agonist activity, while d-isomer is suggested to have only low or no affinity for beta 1-adrenoceptors.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL213 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8951157 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8951157
Effects of optical isomers of methylephedrine (MEP) on the spontaneous beating rate of isolated right atrium of normal and reserpinized rat were investigated to assess direct and indirect actions on beta 1-adrenoceptors. l-MEP (10(-5) - 3 x 10(-4) M) showed slight increase in heart rate. In addition, d-MEP (3 x 10(-5) - 3 x 10(-4) M) caused a decrease in heart rate. Positive chronotropic effects of l-MEP was attenuated by pretreatment with atenolol ( a selective beta 1-adrenoceptor antagonist) or reserpine treatment (8 mg/kg, s.c.). l-MEP has beta 1-adrenoceptor agonist activity, while d-MEP is suggested to have only low or no affinity for beta 1-adrenoceptors. The relatively weak activity of l-MEP is believed to be mainly mediated by released noradrenaline.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C87053
Created by
admin on Mon Mar 31 18:55:32 GMT 2025 , Edited by admin on Mon Mar 31 18:55:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1546444
Created by
admin on Mon Mar 31 18:55:32 GMT 2025 , Edited by admin on Mon Mar 31 18:55:32 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID701021165
Created by
admin on Mon Mar 31 18:55:32 GMT 2025 , Edited by admin on Mon Mar 31 18:55:32 GMT 2025
|
PRIMARY | |||
|
SHS9PGQ2LS
Created by
admin on Mon Mar 31 18:55:32 GMT 2025 , Edited by admin on Mon Mar 31 18:55:32 GMT 2025
|
PRIMARY | |||
|
DB11278
Created by
admin on Mon Mar 31 18:55:32 GMT 2025 , Edited by admin on Mon Mar 31 18:55:32 GMT 2025
|
PRIMARY | |||
|
SHS9PGQ2LS
Created by
admin on Mon Mar 31 18:55:32 GMT 2025 , Edited by admin on Mon Mar 31 18:55:32 GMT 2025
|
PRIMARY | |||
|
m7410
Created by
admin on Mon Mar 31 18:55:32 GMT 2025 , Edited by admin on Mon Mar 31 18:55:32 GMT 2025
|
PRIMARY | Merck Index | ||
|
214-859-6
Created by
admin on Mon Mar 31 18:55:32 GMT 2025 , Edited by admin on Mon Mar 31 18:55:32 GMT 2025
|
PRIMARY | |||
|
1201-56-5
Created by
admin on Mon Mar 31 18:55:32 GMT 2025 , Edited by admin on Mon Mar 31 18:55:32 GMT 2025
|
PRIMARY | |||
|
C99576
Created by
admin on Mon Mar 31 18:55:32 GMT 2025 , Edited by admin on Mon Mar 31 18:55:32 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)